Ivo Kraljić

A more objective staging of advanced prostate cancer—routine recognition of malignant endocrine structures: The assessment of serum TPS, PSA, and NSE values

Marko Tarle, Ksenija Kovačić, Snjez̆ana Frković‐Grazio et al. · The Prostate · 1994 · 34 citations

Medicine, Oncology, Urology +17

Comparison between NK cell activity and prostate cancer stage and grade in untreated patients: correlation with tumor markers and hormonal serotest data

Marko Tarle, Ivo Kraljić, Maja Kaštelan · Urological Research · 1993 · 29 citations

Medicine, Oncology, Urology +12

NK cell activity in treated prostate cancer patients as a probe for circulating tumor cells: Hormone regulatory effects in vivo

Maja KašCtelan, Marko Tarle, Ivo Kraljić · The Prostate · 1992 · 24 citations

Medicine, Immunology, Oncology +12

Analysis of NK cell activity, lymphocyte reactivity to mitogens and serotest PSA and TPS values in patients with primary and disseminated prostate cancer, PIN and BPH.

Marija Kaštelan, K Kovacić, Roberto Gomes Tarlé et al. · PubMed · 1997 · 15 citations

Medicine, Immunology, Oncology +16

Oral estramustine therapy in serum chromogranin A-positive stage D3 prostate cancer patients.

M. Zaky Ahel, Ksenija Kovačić, Ivo Kraljić et al. · PubMed · 2001 · 14 citations

Medicine, Oncology, Urology +17